Finding groups near you ...
  1.   Global initiatives
  2.    Public
The Big Catch-up is a global initiative to close immunization gaps caused by the backsliding of immunization coverage during the COVID-19 pandemic, restore global immunization levels, and strengthen i...

The Big Catch-up is a global initiative to close immunization gaps caused by the backsliding of immunization coverage during the COVID-19 pandemic, restore global immunization levels, and strengthen immunization systems so that catch-up activities become an integral part of immunization programmes. This page brings together Big Catch-up documents including guidance, frequently asked questions (FAQs), and monitoring, evaluation, and learning (MEL) forms and tools, as well as a forum for sharing country experiences, updates, and materials.

  1.   Data
  2.    Private

A curated group of immunization research experts who may be called on for guidance and perspective in the context of the IA2030's Strategic Priority 7 on Research and Immunization.

The massive experience worldwide vaccinating adults against COVID-19 provides a valuable opportunity to strengthen and expand adult immunization for existing vaccines (influenza, Respiratory Syncytial...

The massive experience worldwide vaccinating adults against COVID-19 provides a valuable opportunity to strengthen and expand adult immunization for existing vaccines (influenza, Respiratory Syncytial Virus (RSV), tetanus/pertussis containing vaccines, pneumococcal vaccines, zoster, Mpox…) and for those in the pipeline (i.e. new generation of tuberculosis vaccines). Many countries are providing vaccines for adults through their routine services and exploring new entry points as part of primary health care (PHC).

This Community of Practice (CoP) on Adult Immunization aims to create a dynamic and inclusive platform (membership is not restricted) for sharing knowledge, best practices, and peer-learning on adult immunization and with your contributions move towards a world where everyone, everywhere, at EVERY AGE fully benefits from vaccines for good health and well-being, in alignment with IA2030 vision. This CoP is managed by WHO with contributions of many partners.

  1.   Global initiatives
  2.    Private
The Global Yellow Fever Laboratory Network (GYFLaN) Group is private, where members are staff within the GYFLaN in the African and Eastern Mediterranean regions, and Region of the Americas, and member...

The Global Yellow Fever Laboratory Network (GYFLaN) Group is private, where members are staff within the GYFLaN in the African and Eastern Mediterranean regions, and Region of the Americas, and members of the EYE-Strategy Yellow Fever Laboratory Technical Working Group (EYE-LTWG). 

The purpose of this group is to house and share documents of use to the GYFLaN, facilitate discussion and collaboration, and provide a single hub for information specific to the GYFLaN. 

 

  1.   Global initiatives
  2.    Private
The EYE-LTWG Group is a place for the Laboratory Technical Working Group of the EYE Strategy to discuss topics specific to the Group. This includes access to scheduled meeting-related material, LTWG-p...

The EYE-LTWG Group is a place for the Laboratory Technical Working Group of the EYE Strategy to discuss topics specific to the Group. This includes access to scheduled meeting-related material, LTWG-produced and group-relevant publications, LTWG annual conference announcements and information, recordings and photographs of group-related activities, and Group member contact information. This group is private.

  1.   Programme management
  2.    Public
This group is set-up for peer-to-peer learning and sharing resources related to Supportive supervision. Evidence shows that supportive supervision enhances communication, workforce performance and pro...

This group is set-up for peer-to-peer learning and sharing resources related to Supportive supervision. 
Evidence shows that supportive supervision enhances communication, workforce performance and promotes professional development. Ultimately, this approach leads to a more engaged and productive workforce, contributing to the overall success of the immunization programme.

 

Communauté de pratique des utilisateurs du réfrigérateur Toyota Landcruiser réfrigéré avec le réfrigérateur CF850 de B Medical Systems

Community of practice of the users of the Toyota Landcruiser Refrigerated with B Medical Systems' CF850 refrigerator

  1.   Global initiatives
  2.    Private
The iSC CoP aims to improve communication and facilitate exchanges beyond the iSC2 by connecting with key stakeholders at country, regional and global levels. Through the platform, we will be able to ...

The iSC CoP aims to improve communication and facilitate exchanges beyond the iSC2 by connecting with key stakeholders at country, regional and global levels. Through the platform, we will be able to connect across with these diverse stakeholders while supporting efforts that strengthen the implemenattion of the comprehensive vaccine management approach as well as the investment priorities in the Gavi 5.0 iSC strategy.

 

  1.   Partners & projects
  2.    Public
The Vaccine Innovation Prioritisation Strategy (VIPS) represents an unprecedented three-year collaboration between the Gavi Secretariat, World Health Organization (WHO), Bill & Melinda G...

The Vaccine Innovation Prioritisation Strategy (VIPS) represents an unprecedented three-year collaboration between the Gavi Secretariat, World Health Organization (WHO), Bill & Melinda Gates Foundation (BMGF), United Nations Children’s Fund (UNICEF) and PATH– known as the VIPS Alliance - to develop a single integrated framework to evaluate and prioritise vaccine product innovations and to drive these innovations forward.

Innovative approaches are needed to help to address immunisation barriers and achieve immunisation coverage and equity goals. Vaccine product innovations offer important means to simplify logistics, increase the acceptability and safety of immunisation, minimise missed opportunities, and facilitate outreach. There is increasing recognition of the need to employ targeted solutions to extend vaccine access to reach the unreached.

The VIPS process involved in-depth research, stakeholder consultations, and development and application of a methodology capable of evaluating a variety of technologies at different stages along the product development pipeline continuum. The work required understanding countries’ needs to consider the expected financial and non-financial impacts of innovations; developing common principles across the Alliance to assess the long-term benefits of product innovations; and convening a platform of stakeholders to articulate a clear and aligned perspective on priority innovations.

By prioritising innovations in vaccine products, the goal of VIPS is to provide greater clarity to manufacturers and partners to inform and influence investment decisions. VIPS outcomes also represent a first step to mobilise key decision-makers and funders and chart a strategic pathway forward for the prioritised innovations.

The VIPS – Vaccine Innovation Prioritisation Strategy – process concluded in May 2020 with a decision to prioritise 3 innovations / approaches for which the Alliance will engage in to advance development, policy and access:

  • Upstream novel delivery device – Microarray patches,
  • A combined formulation, regulatory, and novel programmatic approach to vaccine management – Heat stable and Controlled Temperature Chain qualified vaccines, and 
  • An implementation/system innovation – Barcodes on primary packaging

The next steps for the VIPS Alliance are to define end-to-end strategies for the three prioritised innovations, including developing clear action plans to accelerate their advancement to uptake and impact.

VIPS methodology and outcomes summary 

  1.   Global initiatives
  2.    Public
Ce groupe est destiné aux membres intéressés par les formations de l'OMS Scholar. Que vous ayez participé ou que vous soyez intéressé à participer à l'une des formations, ce groupe vous permet d'obten...

Ce groupe est destiné aux membres intéressés par les formations de l'OMS Scholar. Que vous ayez participé ou que vous soyez intéressé à participer à l'une des formations, ce groupe vous permet d'obtenir des mises à jour, de partager des informations, d'entrer en contact avec d'autres anciens élèves, d'élargir votre réseau, etc.

  1.   Global initiatives
  2.    Public
This group is for members interested in WHO Scholar courses. Whether you participated or are interested in participating in one of the trainings, this group is your place to get updates, share informa...

This group is for members interested in WHO Scholar courses. Whether you participated or are interested in participating in one of the trainings, this group is your place to get updates, share information, connect with fellow alumni, etc. 

  1.   Country
  2.    Public
The EAC is a regional intergovernmental organisation of 6 Partner States: the Republics of Burundi, Kenya, Rwanda, South Sudan, the United Republic of Tanzania, and the Republic of Uganda, with its he...

The EAC is a regional intergovernmental organisation of 6 Partner States: the Republics of Burundi, Kenya, Rwanda, South Sudan, the United Republic of Tanzania, and the Republic of Uganda, with its headquarters in Arusha, Tanzania. It is home to 177 million people, with a land area of 2.5 million square km  and a combined GDP of US$ 193 billion (EAC Statistics for 2019).

The work of the EAC is guided by its Treaty, which mandates Partner States to collaborate and deepen integration on political, economic, social and cultural dimensions with a view to improve the quality of life of the citizen. It is under this framework particularly Article 118 of the Treat authorizes the Partner States to cooperate with eventual integration on Health. This how the EAC formed the Regional Centre of Excellence for Vaccines, Immunisation and Health supply Chain Management (EAC RCE-VIHSCM). The RCE works closely with EAC Expanded Program for Immunisation (EPI), National Medical Stores, the National Drug Authorities  and, the public universities and other Supply Chain Management (SCM) leaders to find innovative solutions to solve existing and emerging challenges to immunisation and health supply systems in the region.

The creation of this community of practice (CoP) with support from WHO TechNet-21 is thus a vehicle to institutionalise closer collaboration especially in the face of COVID-19 onslaught. This will help the EAC counter the impact of the pandemic on routine immunisation and to prepare itself for the advent of corona virus vaccine. Besides the EAC-Immunisation Managers, the CoP will aim to pool together other practitioners of health supply chain as well as expertise from UN agencies like Gavi, UNICEF, WHO and UNFPA and reputable CSOs.

  1.   Vaccines & delivery devices
  2.    Private
A community of practice and resource portal for professionals supporting national immunization Our Story The Vaccine Procurement Practitioners Network (VPPN) is a network of government officials and...

A community of practice and resource portal for professionals supporting national immunization

Our Story

The Vaccine Procurement Practitioners Network (VPPN) is a network of government officials and technical experts who exchange knowledge and learn from each other’s experiences online and at face-to-face events. The network was formed following the first Vaccine Procurement Practitioners Exchange Forum (VPPEF) in 2015, hosted by UNICEF Supply Division in Copenhagen, Denmark.

Our Purpose

The purpose of the VPPN is to improve vaccine procurement outcomes for children's health, by coming together as a global membership and openly sharing practical experiences and lessons learned in order to strengthen country-driven strategic vaccine procurement and innovation.

Our Values

Committed to Children: We are a dedicated network, committed to improving child health outcomes.
Knowledge Sharing: We engage in an open exchange of opinions, observations and questions that benefit our fellow professionals facing similar challenges.
Global: We are a global community committed to regular interaction with our fellow members to support the vital work begun during the first VPPEF in 2015.
Expertise: We are a network of procurement professionals, focused on sharing our knowledge for the benefit of our fellow members.

Our Membership Criteria

  1. Field of work: role related to vaccine procurement
    This includes such people as national buyers, national warehouse stock managers, …
  2. Employer: focus on government stakeholders in Ministries of Health or Finance
  3. Partners: all intergovernmental and non-governmental organisations (IGOs and NGOs) supporting vaccine procurement

Our Partners

These organizations and initiatives work together with UNICEF and the VPPN toward improving national-level immunization practices: 

 

gavi sm

bill melinda gates foundation logo2

 

WHOr4d logo sm

 

 

  1.   Disease
  2.    Public
"On dit qu'une personne sage apprend de ses erreurs. Une personne plus sage apprend des erreurs des autres. Mais la personne la plus sage apprend des succès des autres" Proverbe zen adapté par J...

"On dit qu'une personne sage apprend de ses erreurs. Une personne plus sage apprend des erreurs des autres. Mais la personne la plus sage apprend des succès des autres"

Proverbe zen adapté par John C. Maxwell

 

Bienvenue dans le groupe de gestion du VPOm2!

Les ateliers GPEI sur la gestion du VPOm2 organisés à Istanbul en 2018 et à Nairobi en 2019 ont permis de renforcer les capacités d'une centaine d'experts en logistique de la chaîne du froid et en gestion des vaccins. Le but de ces ateliers était de renforcer les capacités des experts en gestion du VPOm2 lors des campagnes de riposte aux épidémies.

Un paquet de formation complet sur la logistique de la chaîne du froid et la gestion du mOPV2 a été mis au point pour équiper les experts / consultants et les points focaux de la poliomyélite à mieux soutenir les pays lors des interventions face aux épidémies de poliomyélite et durant l'évaluation de la réponse aux épidémies (OBRA) des pays.

Ces experts formés ont recommandé de créer et de développer une communauté de pratiques - CdP - spécialisée dans la logistique de la chaîne du froid et la gestion des vaccins VPOm2 . L'objectif de la CdP est d'échanger des connaissances, des mises à jour techniques, des résultats d'OBRAs, les SitReps, de nouveaux outils et directives, ainsi que les meilleures pratiques des pays dans ce domaine.

La CdP encourage l’intelligence collective pour permettre à ses membres de révéler leur plus haut potentiel et leur plus grande expertise grâce à la collaboration et à l’innovation dans le cadre d’une relation de renforcement synergique. Cette discussion de groupe offre aux membres de la CdP l’occasion de partager leurs expériences et leurs innovations. Dans les prochains mois, nous partagerons d'autres moyens d'améliorer la communication et la collaboration au sein de notre communauté.

 

Rejoignez notre CdP et partagez avec nous votre expérience et les innovations liées à la logistique de la chaine du froid et la gestion du VPOm2 pour la réponse aux épidémies dans les pays!

 

  1.   Disease
  2.    Public
"It’s said that a wise person learns from his mistakes. A wiser one learns from others’ mistakes. But the wisest person of all learns from others’ successes" Zen proverb adapted by John C. Maxwell  ...

"It’s said that a wise person learns from his mistakes. A wiser one learns from others’ mistakes. But the wisest person of all learns from others’ successes"

Zen proverb adapted by John C. Maxwell

 

Welcome to the mOPV2 management Group!

The GPEI mOPV2 Management workshops held in Istanbul in 2018 and Nairobi in 2019, enabled building the capacity of almost hundred experts in cold chain logistics and vaccine management. The purpose of these workshops was to reinforce the capacity of experts in mOPV2 management.

A comprehensive mOPV2 Cold Chain, logistics and vaccine management training package was developed to equip experts/consultants and polio focal points to better support countries during polio outbreak response and Oubreak Response Assessment (OBRA). 

The experts recommended creating and cultivating a Polio Response Outbreak Community of Practices – CoP – specialized in mOPV2 cold chain logistics and vaccine management. The purpose of the CoP is to exchange knowledge, technical updates, OBRA outcomes, SitReps, new tools and guidelines, as well as best practices from countries.

The CoP fosters collective intelligence to enable its members to reveal their highest potential and expertise through collaboration and innovation in synergic nurturing relationship. This Group Discussion gives the opportunity to CoP members to share experience and innovations. In future issues, we will share additional ways to improve communication and collaboration among our community.

Please join our CoP and share with us your experience and innovations related to mOPV2 CCL & VM for Outbreak Response in countries.

  1.   Data
  2.    Public
This is a group for people having to engage on vaccination coverage surveys wishing to promote improved quality.  Useful material can be found at https://www.technet-21.org/en/top...

This is a group for people having to engage on vaccination coverage surveys wishing to promote improved quality. 

Useful material can be found at https://www.technet-21.org/en/topics/vaccination-coverage-surveys and https://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index2.html

 

  1.   Data
  2.    Public
Ce groupe s'adresse aux personnes impliquées dans les enquêtes de couverture vaccinale et souhaitant en améliorer la qualité.  Vous trouverez tout le matériel nécessaire sur https://www.technet-21.or...

Ce groupe s'adresse aux personnes impliquées dans les enquêtes de couverture vaccinale et souhaitant en améliorer la qualité. 


Vous trouverez tout le matériel nécessaire sur https://www.technet-21.org/en/topics/vaccination-coverage-surveys et https://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index2.html

  1.   Country
  2.    Public
Every year, the WHO European Region marks European Immunization Week (EIW) to promote immunization as vital to preventing diseases and protecting life. This year, on 24–30 April 2019, the campaign ai...

Every year, the WHO European Region marks European Immunization Week (EIW) to promote immunization as vital to preventing diseases and protecting life.

This year, on 24–30 April 2019, the campaign aims to raise awareness of the benefits of vaccines and to celebrate the “vaccine heroes” who contribute in so many ways to protecting lives through vaccination.

To find out more about the EIW, please visit WHO Europe website: www.euro.who.int/eiw2019

You are invited to join, follow and share the information and images on the WHO Europe Facebook EIW 2019 event

  1.   Supply chain & logistics
  2.    Public

A group for users of the new Effective Vaccine Management (EVM) 2 assessment tool. 

No groups are currently available. Be the first to create one today!
Unable to load tooltip content.